Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study

The Lancet Infectious Diseases

Volumn 14, Issue 11, 2014, Pages 1083-1089

  Bekker, Vincent ^a   Bijlsma, Merijn W ^b   van de Beek, Diederik ^b   Kuijpers, Taco W ^a   Van der Ende, Arie ^b,c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Amsterdam Infection and Immunity   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL MENINGITIS; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CHILDHOOD DISEASE; ESCHERICHIA COLI INFECTION; FEMALE; GENOTYPE; GROUP B STREPTOCOCCAL INFECTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NEWBORN; NEWBORN DISEASE; PRACTICE GUIDELINE; PREMATURE LABOR; STREPTOCOCCUS AGALACTIAE; CLASSIFICATION; EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI INFECTIONS; GENETICS; INFANT; INFECTION CONTROL; ISOLATION AND PURIFICATION; MENINGITIS, BACTERIAL; MICROBIOLOGY; PROCEDURES; SEPSIS; STREPTOCOCCAL INFECTIONS;

EPIDEMIOLOGICAL MONITORING; ESCHERICHIA COLI INFECTIONS; FEMALE; GENOTYPE; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; MENINGITIS, BACTERIAL; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; SEPSIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 84908306422     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70919-3     Document Type: Article

References (35)

1. Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E. coli disease continues. Pediatrics 2011, 127:817-826.
2. Le Doare K, Heath PT An overview of global GBS epidemiology. Vaccine 2013, 31(suppl 4):D7-12.
3. Schuchat A Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev 1998, 11:497-513.
4. Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 2012, 379:547-556.
5. Dagnew AF, Cunnington MC, Dube Q, et al. Variation in reported neonatal group B streptococcal disease incidence in developing countries. Clin Infect Dis 2012, 55:91-102.
6. Boyer KM, Gotoff SP Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986, 314:1665-1669.
7. Moore MR, Schrag SJ, Schuchat A Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis. Lancet Infect Dis 2003, 3:201-213.
8. Nederlandse vereniging voor obstetrie en gynaecologie. Prevention of neonatal group-b streptococcal disease in the Netherlands [Preventie van neonatale groep-B-streptokokkenziekte] version 2.0. NVOG-richtlijn 2012.
9. Jones N, Bohnsack JF, Takahashi S, et al. Multilocus sequence typing system for group B streptococcus. J Clin Microbiol 2003, 41:2530-2556.
10. Manning SD, Springman AC, Lehotzky E, et al. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J Clin Microbiol 2009, 47:1143-1148.
11. Luan SL, Granlund M, Sellin M, et al. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J Clin Microbiol 2005, 43:3727-3733.
12. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849-1859.
13. Bacterial meningitis in the Netherlands; Netherlands Reference Laboratory for Bacterial Meningitis (AMC/RIVM). Annual report 2008 Academic Medical Center (AMC) and National Institute of Public Health and the Environment (RIVM), (accessed Oct 1, 2014). https://www.amc.nl/web/file?uuid=d8ec1451-b6c4-4af5-8eb6-24c801848229&owner=4d928ce4-e557-4531-8337-ee2442f7f9d8&contentid=5626.
14. Spanjaard L, Bol P, Ekker W, Zanen HC The incidence of bacterial meningitis in the Netherlands-a comparison of three registration systems, 1977-1982. J Infect 1985, 11:259-268.
15. Trijbels-Smeulders MA, Kimpen JL, Kollee LA, et al. Serotypes, genotypes, and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitis before and after introduction of antibiotic prophylaxis. Pediatr Infect Dis J 2006, 25:945-948.
16. Bohnsack JF, Whiting A, Gottschalk M, et al. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J Clin Microbiol 2008, 46:1285-1291.
17. Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PC, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed 2007, 92:F271-F276.
18. Trijbels-Smeulders MA, Kollee LA, Adriaanse AH, Kimpen JL, Gerards LJ Neonatal group B streptococcal infection: incidence and strategies for prevention in Europe. Pediatr Infect Dis J 2004, 23:172-173.
19. Schrag SJ, Zywicki S, Farley MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000, 342:15-20.
20. Phares CR, Lynfield R, Farley MM, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 2008, 299:2056-2065.
21. Rodriguez-Granger J, Alvargonzalez JC, Berardi A, et al. Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project. Eur J Clin Microbiol Infect Dis 2012, 31:2097-2104.
22. The Prevention of Early-onset Neonatal Group B Streptococcal Disease. Green-top Guideline 12 A.D. Royal College of Obstetricians and Gynaecologists, (accessed 24th Sept). http://www.guideline.gov/content.aspx?id=37904.
23. Glasgow TS, Young PC, Wallin J, et al. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants. Pediatrics 2005, 116:696-702.
24. Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med 2009, 360:2626-2636.
25. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
26. Lamagni TL, Keshishian C, Efstratiou A, et al. Emerging trends in the epidemiology of invasive group B streptococcal disease in England and Wales, 1991-2010. Clin Infect Dis 2013, 57:682-688.
27. Kalliola S, Vuopio-Varkila J, Takala AK, Eskola J Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J 1999, 18:806-810.
28. Heath PT, Balfour G, Weisner AM, et al. Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 2004, 363:292-294.
29. Trends in perinatal group B streptococcal disease-United States, 2000-2006. MMWR Morb Mortal Wkly Rep 2009, 58:109-112.
30. Andersen J, Christensen R, Hertel J Clinical features and epidemiology of septicaemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr 2004, 93:1334-1339.
31. Fluegge K, Wons J, Spellerberg B, et al. Genetic differences between invasive and noninvasive neonatal group B streptococcal isolates. Pediatr Infect Dis J 2011, 30:1027-1031.
32. Bisharat N, Crook DW, Leigh J, et al. Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol 2004, 42:2161-2167.
33. Seifert KN, Adderson EE, Whiting AA, et al. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 2006, 152:1029-1040.
34. Da Cunha V, Davies MR, Douarre PE, et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun 2014, 5:4544.
35. Akker-van Marle ME, Rijnders ME, Dommelen P, et al. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG 2005, 112:820-826.